Of note, K‐Ras, a potent oncogenic driver of pancreatic cancer, which lies upstream of Nrf2 6, was unaffected by UHRF1 depletion (Figure 3E) from Suit‐2 cells, which harbour oncogenic K‐Ras. Here, KRAS is linked to pancreatic neoplasm.